首页> 外文OA文献 >Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS)

【2h】

Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS)

机译：与泛型与授权通用不良事件报告的品牌与授权通用不良事件报告的方法论考虑不良事件报告系统（FAEERS）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Md. Motiur Rahman; Yasser Alatawi; Ning Cheng; Jingjing Qian; Peggy L. Peissig; Richard L. Berg; David C. Page; Richard A. Hansen;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS) [J] . Md. Motiur Rahman, Yasser Alatawi, Ning Cheng, Clinical drug investigation . 2017,第12期

机译：与泛型与授权通用不良事件报告的品牌与授权通用不良事件报告的方法论考虑不良事件报告系统（FAEERS）
2. Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) [J] . Md. Motiur Rahman, Yasser Alatawi, Ning Cheng, Epilepsy research . 2017,第期

机译：美国食品和药物管理局的品牌与通用抗癫痫药物不良事件报告率的普通抗癫痫药物的比较不良事件报告系统（FAEERS）
3. Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database [J] . Kazuyo Shimada, Shiori Hasegawa, Satoshi Nakao, International Journal of Medical Sciences . 2019,第9期

机译：使用食物和药物管理局的直接口服抗凝血剂引起的出血不良反应的不良反应谱不同，使用食品和药物管理局不良事件报告系统（FAEERS）数据库和日本不利药物事件报告（JADER）数据库
4. Investigating the accuracy of the openFDA API using the FDA Adverse Event Reporting System (FAERS) [C] . Shin Jeyong IEEE International Congress on Big Data . 2014

机译：使用FDA不良事件报告系统（FAERS）调查openFDA API的准确性
5. Study on impacts of promotion of generic drug utilization on spontaneous adverse event reports and drug safety assessment at the post-market stage [D] . TAKAMI, Akina 2019

机译：上市后阶段推广仿制药利用对自发不良事件报告和药物安全评估的影响
6. Methodological considerations for comparison of brand versus generic versus authorized generic adverse event reports in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) [O] . Md. Motiur Rahman, Yasser Alatawi, Ning Cheng, -1

机译：在美国食品药品管理局不良事件报告系统（FAERS）中比较品牌非专利和授权非专利不良事件报告的方法学考虑
7. PHP92 Serious adverse Drug events reported to the Food and Drug Administration (FDA): analysis of the FDA adverse event reporting system (FAERS) 2006-2011 database [O] . Sonawane K.B., Hansen R.A. 2015

机译：PHP92向食品药品监督管理局（FDA）报告的严重不良药物事件：FDA不良事件报告系统（FAERS）2006-2011数据库的分析

Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS)

著录项

引文网络

相似文献

相关主题

期刊订阅